相关实验视频

Updated: Jul 20, 2025

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

新兴的超病毒性马雷克病病毒变种显著克服商业疫苗所提供的保护

Jin-Ling Liu^1,2, Man Teng^1,2, Lu-Ping Zheng^1,2

¹Key Laboratory of Animal Immunology, Ministry of Agriculture and Rural Affairs of China & Henan Provincial Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China.

|July 29, 2023

概括

中国的新型高病毒性马雷克病病毒 (MDV) 菌株正在挑战现有疫苗. 这项研究强调,迫切需要新型马雷克病 (MD) 疫苗,以应对这些新出现的威胁,并保护家禽的健康.

科学领域:

鸟类病理学鸟类病理学
病毒学病毒学
免疫学免疫学免疫学

背景情况:

由马雷克病病毒 (MDV) 引起的马雷克病 (MD) 是一种严重的禽类免疫抑制和瘤性疾病,造成了巨大的经济损失.
最近在接种疫苗的群体中爆发的疫情表明需要了解当前的MDV病原性和疫苗疗效.

研究的目的:

来自中国的新分离的MDV菌株的致病性分析.
评估商业MD疫苗对这些菌株的免疫保护有效性.

主要方法:

从瘤母中分离和鉴定7种MDV菌株的特征.
感染实验以评估病原性,包括累积发病率,死亡率和粗瘤发生率.
对四种商用MD疫苗进行针对特定MDV分离物 (SDCW01) 和其他参考菌株的评估.

主要成果:

在7个孤立的MDV菌株中,有4个被确定为高病毒性MDV (HV-MDV) 菌株.
这些HV-MDV菌株表现出高致病性,导致100%的累积发病率和的显著死亡率.
商用MD疫苗显示出有限的保护,保护指数在28%至50%之间,表明疫苗免疫的突破.

结论:

在中国出现的HV-MDV变种可以克服广泛使用的经典MD疫苗所提供的保护.
迫切需要开发新的,更有效的MD疫苗,以应对这些新出现的HV-MDV菌株带来的挑战.
持续控制MD需要创新的疫苗策略来对抗正在演变的HV-MDV菌株.

关键词:

这是一个MDVMDV.马雷克的疾病是马雷克的疾病.在致癌性方面.病原性病原性病原性保护指数保护指数疫苗疫苗疫苗疫苗

更多相关视频

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

相关概念视频

Vaccinations

Vaccinations

Viral Recombination

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

Cross-reactivity

Cross-reactivity

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...